Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Ocumension Therapeutics ( (HK:1477) ).
Ocumension Therapeutics has announced that its board of directors will meet on March 31, 2025, to review and approve the company’s annual financial results for the year ending December 31, 2024. The board will also consider recommending a final dividend, which could impact shareholder returns and reflect the company’s financial health.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, focusing on the healthcare industry. It is listed on the Hong Kong Stock Exchange and is involved in developing and commercializing ophthalmic therapies.
YTD Price Performance: 6.89%
Average Trading Volume: 2,183,894
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$3.95B
For an in-depth examination of 1477 stock, go to TipRanks’ Stock Analysis page.